GTS511 is a EAAT2 Activator. Pharmacokinetic profiles (PK) of GTS511 show a >6 h half-life and higher bioavailability in plasma and the brain under all three routes of administration in rats. GTS511 can be further developed to treat neurological disorders caused by excitotoxicity
Molecular Weight:
339.39
CAS Number:
[920227-84-5]
Formula:
C19H21N3O3
Target:
Others
T68345
* VAT and and shipping costs not included. Errors and price changes excepted